A Translational Study of the ATR Inhibitor Berzosertib as Monotherapy in Four Molecularly Defined Cohorts of Advanced Solid Tumors.
Saved in:
| Title: | A Translational Study of the ATR Inhibitor Berzosertib as Monotherapy in Four Molecularly Defined Cohorts of Advanced Solid Tumors. |
|---|---|
| Authors: | Cote GM; Mass General Cancer Center, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Kochupurakkal BS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Do K; Harvard Medical School, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Bullock A; Harvard Medical School, Boston, Massachusetts.; Beth Israel Deaconess Medical Center, Boston, Massachusetts., Cheng ML; Harvard Medical School, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Muzikansky A; Mass General Cancer Center, Boston, Massachusetts., McLoughlin DE; Mass General Cancer Center, Boston, Massachusetts., Cleary JM; Harvard Medical School, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Gao X; Mass General Cancer Center, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Parikh A; Mass General Cancer Center, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Park JC; Mass General Cancer Center, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Weekes CD; Mass General Cancer Center, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Yeku O; Mass General Cancer Center, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Zou L; Mass General Cancer Center, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Duke University, Durham, North Carolina., Shapiro GI; Harvard Medical School, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. |
| Source: | Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2025 Jan 06; Vol. 31 (1), pp. 35-44. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39453756 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: A Translational Study of the ATR Inhibitor Berzosertib as Monotherapy in Four Molecularly Defined Cohorts of Advanced Solid Tumors. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Cote+GM%22">Cote GM</searchLink>; Mass General Cancer Center, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Kochupurakkal+BS%22">Kochupurakkal BS</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Do+K%22">Do K</searchLink>; Harvard Medical School, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Bullock+A%22">Bullock A</searchLink>; Harvard Medical School, Boston, Massachusetts.; Beth Israel Deaconess Medical Center, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Cheng+ML%22">Cheng ML</searchLink>; Harvard Medical School, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Muzikansky+A%22">Muzikansky A</searchLink>; Mass General Cancer Center, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22McLoughlin+DE%22">McLoughlin DE</searchLink>; Mass General Cancer Center, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Cleary+JM%22">Cleary JM</searchLink>; Harvard Medical School, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Gao+X%22">Gao X</searchLink>; Mass General Cancer Center, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Parikh+A%22">Parikh A</searchLink>; Mass General Cancer Center, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Park+JC%22">Park JC</searchLink>; Mass General Cancer Center, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Weekes+CD%22">Weekes CD</searchLink>; Mass General Cancer Center, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Yeku+O%22">Yeku O</searchLink>; Mass General Cancer Center, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Zou+L%22">Zou L</searchLink>; Mass General Cancer Center, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Duke University, Durham, North Carolina.<br /><searchLink fieldCode="AU" term="%22Shapiro+GI%22">Shapiro GI</searchLink>; Harvard Medical School, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229502500%22">Clinical cancer research : an official journal of the American Association for Cancer Research</searchLink> [Clin Cancer Res] 2025 Jan 06; Vol. 31 (1), pp. 35-44. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%22">American Association for Cancer Research </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9502500 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1557-3265 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210780432%22">10780432 </searchLink><i>NLM ISO Abbreviation: </i>Clin Cancer Res <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39453756 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1158/1078-0432.CCR-24-1867 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 35 Titles: – TitleFull: A Translational Study of the ATR Inhibitor Berzosertib as Monotherapy in Four Molecularly Defined Cohorts of Advanced Solid Tumors. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Cote GM – PersonEntity: Name: NameFull: Kochupurakkal BS – PersonEntity: Name: NameFull: Do K – PersonEntity: Name: NameFull: Bullock A – PersonEntity: Name: NameFull: Cheng ML – PersonEntity: Name: NameFull: Muzikansky A – PersonEntity: Name: NameFull: McLoughlin DE – PersonEntity: Name: NameFull: Cleary JM – PersonEntity: Name: NameFull: Gao X – PersonEntity: Name: NameFull: Parikh A – PersonEntity: Name: NameFull: Park JC – PersonEntity: Name: NameFull: Weekes CD – PersonEntity: Name: NameFull: Yeku O – PersonEntity: Name: NameFull: Zou L – PersonEntity: Name: NameFull: Shapiro GI IsPartOfRelationships: – BibEntity: Dates: – D: 06 M: 01 Text: 2025 Jan 06 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1557-3265 Numbering: – Type: volume Value: 31 – Type: issue Value: 1 Titles: – TitleFull: Clinical cancer research : an official journal of the American Association for Cancer Research Type: main |
| ResultId | 1 |